p16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia

International Journal of Gynecological Pathology

Volumn 25, Issue 2, 2006, Pages 187-194

  Hashi, Akihiko ^a   Xu, Jia Ying ^a   Kondo, Tetsuo ^a   Hashi, Keiko ^a   Yuminamochi, Tsutomu ^a   Nara, Masatoshi ^a   Murata, Shin Ichi ^a   Katoh, Ryohei ^a   Hoshi, Kazuhiko ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Human papillomavirus; Lobular endocervical glandular hyperplasia; p16 INK4a expression; Uterine cervix

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P16INK4A; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; ENDOCERVICAL GLANDULAR HYPERPLASIA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RISK; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HYPERPLASIA; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; RISK FACTOR; UTERINE CERVIX; UTERINE CERVIX TUMOR;

ADULT; AGED; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33747154166     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000179612.63085.70     Document Type: Article

References (44)

1. Nucci MR, Clement PB, Young RT. Lobular endocervical glandular hyperplasia, not otherwise specified. Am J Surg Pathol 1999;23:886-91.
2. Mikami Y, Hata S, Melamed J, et al. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 2001;39:364-72.
3. Ishihara K, Kurihara M, Goso Y, et al. Peripheral alpha-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody. Biochem J 1996; 318:409-16.
4. Mikami Y, Hata S, Fujiwara K, et al. Florid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia: worrisome benign mimic of "adenoma malignum". Gynecol Oncol 1999;74:504-11.
5. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
6. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
7. Hording U, Teglbjaerg CS, Visfeldt J, et al. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Gynecol Oncol 1992;46:313-6.
8. Duggan MA, Benoit JL, McGregor SE, et al. Adenocarcinoma in situ of the endocervix: human papillomavirus determination by dot blot hybridization and polymerase chain reaction amplification. Int J Gynecol Pathol 1994;13:143-9.
9. Tenti P, Romagnoli S, Silini E, et al. Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix. Am J Clin Pathol 1996;106:52-6.
10. Andersson S, Rylander E, Larsson B, et al. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001;37:246-50.
11. Zielinski GD, Snijders PJ, Rozendaal L, et al. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol 2003;201:535-43.
12. Sano T, Oyama T, Kashiwabara K, et al. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998;48:580-5.
13. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.
14. Milde-Langosch K, Riethdorf S, Kraus-Pöppinghaus A, et al. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch 2001;439:55-61.
15. Negri G, Egarter-Vigl E, Kasal A, et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. Am J Surg Pathol 2003;27:187-93.
16. Ishikawa M, Fujii T, Masumoto N, et al. Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas. Int J Gynecol Pathol 2003;22:378-85.
17. Schorge J, Lea J, Elias K, et al. p16 as a molecular biomarker of cervical adenocarcinoma. Am J Obstet Gynecol 2004;190:668-73.
18. Tringler B, Gup CJ, Singh M, et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004;35:689-96.
19. Jia-Ying X, Akihiko H, Tetsuo K, et al. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int J Gynecol Pathol 2005;24:296-302.
20. Mikami Y, Kiyokawa T, Hata S, et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod Pathol 2004;17:962-72.
21. Fattaneh A, Tavassoli A, Devilee P. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press, 2003.
22. Ansari-Lari MA, Staebler A, Zaino RJ, et al. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004;28:160-7.
23. Putte GV, Holm R, Kathrine Lie A, et al. Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol 2003;89:140-7.
24. Tsuda H, Hashiguchi Y, Nishimura S, et al. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm. Gynecol Oncol 2003;91:476-85.
25. Riethdorf L, Riethdorf S. Lee KR, et al. Human papillomavirus, expression of p16INK4A, and early endocervical glandular neoplasia. Hum Pathol 2002;33:899-904.
26. Yoon HK, Kim -J, Kang MS. Human papillomavirus 16/18 expression of endocervical glandular lesions: relationship with p53 and MIB-1 expressions. J Korean Med Sci 2001;16:169-74.
27. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
28. Li Y, Nichols MA, Shay JW, et al. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994;54:6078-82.
29. Bringold F, Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 2000;35:317-29.
30. Ishikawa M, Fujii T, Masumoto N, et al. Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas. Int J Gynecol Pathol 2003;22:378-85.
31. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-92.
32. Kamb A. Cell-cycle regulators and cancer. Trends Genet 1995; 11:136-40.
33. Caldas C, Hahn SA, da Costa LT, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
34. Kim JW, Namkoong SE, Ryu SW, et al. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection. Gynecol Oncol 1998;70:75-9.
35. Kim YT, Cho NH, Park SW, et al. Underexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma. Gynecol Oncol 1998;71:38-45.
36. Hirama T, Miller CW, Wilczynski SP, et al. p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines. Mod Pathol 1996;9:26-31.
37. Wong YF, Chung TK, Cheung TH, et al. Methylation of p16INK4A in primary gynecologic malignancy. Cancer Lett 1999;136:231-5.
38. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-99.
39. Lu X, Toki T, Konishi I, et al. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis. Cancer 1998;82:2409-17.
40. Cameron RI, Maxwell P, Jenkins D, et al. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 2002;41:313-21.
41. Ishii K, Hosaka N, Toki T, et al. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch 1998;432:315-22.
42. Hayashi I, Tsuda H, Shimoda T, et al. Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix. Virchows Arch 2003;443:752-60.
43. Tetsuo K, Akihiko H, Shin-ichi M, et al. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: A report of four cases with histochemical and immunohistochemical analysis. Mod Pathol 2005;18:1199-2100.
44. Fukushima M, Shimano S, Yamakawa Y, et al. The detection of human papillomavirus (HPV) in a case of minimal deviation adenocarcinoma of the uterine cervix (adenoma malignum) using in situ hybridization. Jpn J Clin Oncol 1990;20:407-12.